Prevalence of Chronic Diabetic Complications in Newly Diagnosed versus Known Type 2 Diabetic Subjects in a Sample of Alexandria Population, Egypt

被引:20
|
作者
Khalil, Samir Assaad [1 ]
Megallaa, Magdy Helmy [1 ]
Rohoma, Kamel Hemida [1 ]
Guindy, Myriam AbouSeif [2 ]
Zaki, Adel [3 ]
Hassanein, Mohamed [4 ,5 ]
Malaty, Amin Helmy [6 ]
Ismael, Hanaa Mohamed [7 ]
Kharboush, Ibrahim Fahmy [8 ]
El Kafash, Dalal Nasr-Eldein [2 ]
Sallam, Hassan Nooman [9 ]
Desouky, Iman Abdelkareem [6 ]
机构
[1] Alexandria Univ, Fac Med, Dept Internal Med, Unit Diabet & Metab, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Dept Clin Pathol, Alexandria, Egypt
[3] Alexandria Univ, Med Res Inst, Dept Biostat, Alexandria, Egypt
[4] Dubai Hlth Author, Dubai Hosp, Dubai, U Arab Emirates
[5] Cardiff Univ, Cardiff, S Glam, Wales
[6] Alexandria Univ, Fac Med, Dept Ophthalmol, Alexandria, Egypt
[7] Alexandria Univ, High Inst Publ Hlth, Dept Nutr, Alexandria, Egypt
[8] Alexandria Univ, High Inst Publ Hlth, Dept Maternal & Child Hlth, Alexandria, Egypt
[9] Alexandria Reg Ctr Womens Hlth & Dev, Alexandria, Egypt
关键词
Prevalence; diabetic complications; Alexandria; Egypt; chronic; hyperglycemia; MICROVASCULAR COMPLICATIONS; GLUCOSE CONTROL; RISK-FACTORS; FOLLOW-UP; RETINOPATHY; MELLITUS; DISEASE; CARE; ASSOCIATION; MANAGEMENT;
D O I
10.2174/1573399814666180125100917
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In Egypt, data on the prevalence of chronic diabetic complications, which are essential for the adjustment of policies and practices related to diabetes care, are scarce. Therefore, the aim of this study was to determine the frequency of chronic complications of diabetes; namely neuropathy, Diabetic Kidney Disease (DKD), retinopathy and Peripheral Arterial Disease (PAD) in newly-diagnosed versus known type 2 diabetic patients. Subjects & Methods: This is a cross-sectional study that is based on a previous household survey conducted on a representative sample of the population of Alexandria, Egypt. This study included 506 consecutive subjects with type 2 diabetes; 323 patients with previously known T2DM and 183 patients with newly diagnosed T2DM (discovered during the survey). For each participant, a focused history was taken. Comprehensive clinical examination was done including fundus examination, foot examination and assessment of ankle brachial index. Laboratory tests included HbAlc, lipids profile, serum creatinine and Urinary Albumin Creatinine Ratio (UACR). Results: Peripheral neuropathy was detected in 20% of the studied patients; 29.4% of known patients and 3.3% of newly diagnosed patients (p<0.001). Diabetic kidney disease was detected in 33.2% of the studied patients; 46.1% of known patients and 10.4% of newly diagnosed patients (p<0.001). Diabetic retinopathy was detected in 34.6% of the studied patients; 48.3% of known patients and 10.4% of newly diagnosed patients (p<0.001). Peripheral arterial disease was detected in 32.6% of the studied patients; 45.5% of known patients and 9.8% of newly diagnosed patients (p<0.001). In patients with known diabetes, the presence of any of the studied complications (neuropathy, diabetic kidney disease, retinopathy or PAD) was significantly associated with the presence of all other complications (p<0.001). In patients with newly-diagnosed diabetes, the presence of diabetic kidney disease was significantly associated with the presence of retinopathy (p<0.001), with no significant association with PAD (p=0.357). Conclusion: The present study confirms that a considerable proportion of people with T2DM have microvascular complications and/or PAD at the time of, and possibly years before, diagnosis. Having shown that, it is strongly recommended to apply appropriate screening strategies for subjects with diabetes at the time of diagnosis. Finally, these results should be considered as a call for action for the health care planners and providers in our region to plan for early screening for diabetes and its complications to reduce the disease burden in our community.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 50 条
  • [41] Metformin improves oxidative stress and decrease's platelet activation in newly diagnosed type 2 diabetic subjects
    Formoso, Gloria
    De Filippis, Elena A.
    Michetti, Noemi
    Ciabattoni, Giovanni
    Di Fulvio, Patrizia
    Pandolfi, Assunta
    Capani, Fabio
    Davi, Giovanni
    Consoli, Agostino
    DIABETES, 2006, 55 : A111 - A111
  • [42] EFFECTS OF GLUCOSE INGESTION ON SERUM FRACTALKINE LEVELS IN HEALTHY SUBJECTS AND NEWLY DIAGNOSED TYPE 2 DIABETIC PATIENTS
    Baldane, Suleyman
    Kendir, Ismail Can
    Kirac, Cem Onur
    Ipekci, Suleyman
    Tekin, Gulsum
    Unlu, Ali
    Kebapcilar, Levent
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2018, 37 (03) : 373 - 378
  • [43] Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight
    Drivsholm, T
    Olivarius, ND
    Nielsen, ABS
    Siersma, V
    DIABETOLOGIA, 2005, 48 (02) : 210 - 214
  • [44] Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight
    T. Drivsholm
    N. de Fine Olivarius
    A. B. S. Nielsen
    V. Siersma
    Diabetologia, 2005, 48 : 210 - 214
  • [45] High osteoprotegerin serum levels in newly diagnosed type 2 diabetic males with or without known coronary artery disease
    Boyadzhieva, M.
    Hristozov, K.
    Georgiev, S.
    Yordanov, R.
    Chervenkov, T.
    Usheva, N.
    DIABETOLOGIA, 2010, 53
  • [46] A Study on Prevalence and Risk Factors of Diabetic Nephropathy in Newly Detected Type 2 Diabetic Patients
    Ravindran, Rahul
    Kalaivalli, S.
    Srinivasagalu, S.
    Karthik, Lakshminarayanan
    JOURNAL OF DIABETOLOGY, 2020, 11 (02) : 109 - 114
  • [47] Prevalence of microvascular complications in type 2 diabetic patients with dyslipidemia
    Zeryouh, N.
    Messaoudi, N.
    Benyakhlef, S.
    Laalaoua, Y.
    Hamdane, C.
    Rouf, S.
    Latrech, H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [48] Plasma levels of chemerin and adipose triglyceridelipase in newly diagnosed type 2 diabetic patients and type 2 diabetic patients with hypertension
    Yan, Y.
    Li, L.
    Yang, G.
    Liu, Y.
    DIABETOLOGIA, 2009, 52 : S470 - S470
  • [49] INCREASE IN REMISSION RATE IN NEWLY DIAGNOSED TYPE-1 DIABETIC SUBJECTS TREATED WITH AZATHIOPRINE
    HARRISON, LC
    COLMAN, PG
    DEAN, B
    BAXTER, R
    MARTIN, FIR
    DIABETES, 1985, 34 (12) : 1306 - 1308
  • [50] Prevalence of diabetic retinopathy in patients with newly diagnosed type 2 diabetes: A systematic review and meta-analysis
    Cai, Ke
    Liu, Yi-Ping
    Wang, Dan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (01)